Methods involving micromosal prostaglandin E2 synthase

Details for Australian Patent Application No. 2005267227 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Cao, Yang; Sabol, Jeffrey, S.; Ayers, Stephen

Agent Watermark

Pub. Number AU-B-2005267227

PCT Pub. Number WO2006/012259

Priority 60/584,459 30.06.04 US

Filing date 24 June 2005

Wipo publication date 2 February 2006

Acceptance publication date 22 April 2010

International Classifications

G01N 33/88 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving prostaglandins

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/012259 Priority application(s): WO2006/012259

22 April 2010 Application Accepted

  Published as AU-B-2005267227

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267237-Valve actuating apparatuses and methods associated therewith

2005267210-Estrogen receptor modulators